EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Epigallocatechin‐3‐Gallate Suppresses Glioma by Targeting Integrin αvβ3/ FAK / ERK Signaling Axis and Matrix Metalloproteinases

Rui Sun, Yonghan Pan, Ning Yang, Bing Kang, Hong Xiao, Xianglong Tang, Taiping Li iD, Mengjie Zhao

Phytotherapy Research · 2026-06 · 40 (6) · 3079-3093

DOI: 10.1002/ptr.70255 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-03-16. Written by Rui Sun and 7 co-authors. Institution: Neuro-Psychiatric Institute, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China. Major MEDLINE topics: Catechin, Glioma, Integrin alphaVbeta3, MAP Kinase Signaling System. 37 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The Young Talent Training Project for Traditional Chinese Medicine of Nanjing, Nanjing Health Science and Technology Development Special Fund Project, the National Natural Science Foundation of China.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Epigallocatechin‐3‐gallate (EGCG), the most abundant and biologically active catechin in green tea, has been widely reported to exhibit anti‐cancer properties in various tumor types. However, its therapeutic potential and underlying mechanisms on glioma remain ambiguous. This study aimed to investigate the in vitro and in vivo effects of EGCG on glioma, with a specific focus on elucidating its molecular mechanisms, particularly the modulation of integrin‐mediated signaling pathways and matrix metalloproteinases' (MMPs) expressions. The anti‐proliferative effects of EGCG were evaluated in human glioma cell lines (U87, U251, and LN229) using CCK‐8, EdU, and colony formation assays. Cell migration and invasion were assessed by wound healing and transwell assays, while apoptosis was analyzed via flow cytometry. The potential molecular mechanisms underlying the inhibitory effects of EGCG on integrin αvβ3/FAK/ERK signaling pathway and MMP‐2/MMP‐9 were explored by western blotting analyses. In vivo antitumor efficacy of EGCG was evaluated using an intracranial xenograft model in nude mice, with or without co‐administration of temozolomide (TMZ). Toxicity was monitored through body weight changes and histopathological examination. EGCG inhibited cell proliferation with IC 50 values of 127.8 μM (U87), 172.9 μM (U251), and 104.7 μM (LN229) in glioma cells, while inducing apoptosis. Meanwhile, EGCG suppressed migration and invasion of glioma cells in a dose‐dependent manner. Mechanistically, EGCG downregulated the integrin αvβ3/FAK/ERK signaling pathway and inhibited the expression of MMP‐2/MMP‐9. In vivo, EGCG monotherapy exerted notable tumor growth inhibition, and its combination with TMZ led to enhanced therapeutic efficacy without observable systemic toxicity. EGCG exerts potent anti‐glioma effects in inhibiting cell proliferation, migration, and invasion, while promoting apoptosis, mechanically through regulating the integrin αvβ3/FAK/ERK signaling axis and suppressing MMP‐2/MMP‐9 expressions. These findings highlight EGCG as a safe and promising phytochemical adjuvant for glioma therapy, particularly in combination with conventional chemotherapy.

Subjects

MeSH terms (MEDLINE)

CatechinGliomaIntegrin alphaVbeta3MAP Kinase Signaling SystemBrain NeoplasmsHumansAnimalsCell Line, TumorCell MovementMice, NudeCell ProliferationApoptosisMiceMatrix Metalloproteinase 9TemozolomideXenograft Model Antitumor AssaysMatrix Metalloproteinase 2Focal Adhesion Kinase 1Signal TransductionDacarbazine

Author keywords

EGCGMMP‐2/9gliomatemozolomideαvβ3/FAK/ERK axis

Substances

Catechinepigallocatechin gallateIntegrin alphaVbeta3Matrix Metalloproteinase 9TemozolomideMatrix Metalloproteinase 2Focal Adhesion Kinase 1PTK2 protein, humanDacarbazine

Authors and institutions

  • Neuro-Psychiatric Institute, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.
  • Department of Pharmacy, Wuhu Hospital of Traditional Chinese Medicine, Wuhu, China.
  • Department of Neurosurgery, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.
  • Department of Traditional Chinese Medicine, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.

ORCID profiles: Taiping Li

Funding

  • The Young Talent Training Project for Traditional Chinese Medicine of Nanjing
  • Nanjing Health Science and Technology Development Special Fund Project
  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China

Cite

APA

Sun, R., Pan, Y., Yang, N., Kang, B., Xiao, H., Tang, X., Li, T., & Zhao, M. (2026). Epigallocatechin‐3‐Gallate Suppresses Glioma by Targeting Integrin αvβ3/ FAK / ERK Signaling Axis and Matrix Metalloproteinases. Phytotherapy Research, 40(6), 3079-3093. https://doi.org/10.1002/ptr.70255

Vancouver

Sun R, Pan Y, Yang N, Kang B, Xiao H, Tang X, et al. Epigallocatechin‐3‐Gallate Suppresses Glioma by Targeting Integrin αvβ3/ FAK / ERK Signaling Axis and Matrix Metalloproteinases. Phytotherapy Research. 2026;40(6):3079-3093. doi:10.1002/ptr.70255

BibTeX
@article{Sun2026,
  author = {Sun, Rui and Pan, Yonghan and Yang, Ning and Kang, Bing and Xiao, Hong and Tang, Xianglong and Li, Taiping and Zhao, Mengjie},
  title = {Epigallocatechin‐3‐Gallate Suppresses Glioma by Targeting Integrin αvβ3/ FAK / ERK Signaling Axis and Matrix Metalloproteinases},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {3079--3093},
  doi = {10.1002/ptr.70255}
}
Start for free →